Detalhe da pesquisa
1.
Molecular and Clinical Determinants of Acquired Resistance and Treatment Duration for Targeted Therapies in Colorectal Cancer.
Clin Cancer Res
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502113
2.
KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab.
Sci Rep
; 13(1): 21036, 2023 11 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030703